Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats

Molecular Neurobiology

Volumn 49, Issue 1, 2014, Pages 380-385

  Schwalm, Mágada T ^a   Pasquali, Matheus ^b   Miguel, Samantha P ^c   Dos Santos, João Paulo A ^b   Vuolo, Francieli ^a   Comim, Clarissa M ^a   Petronilho, Fabrícia ^c   Quevedo, João ^a   Gelain, Daniel P ^b   Moreira, José Cláudio F ^b   Ritter, Cristiane ^a   Dal Pizzol, Felipe ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Universidade Do sul Catarinense   (Brazil)

Author keywords

Beta amyloid; Brain dysfunction; Neurodegeneration; Sepsis; Synaptophysin

Indexed keywords

ACETYLCYSTEINE; AMYLOID BETA PROTEIN; ANTIOXIDANT; DEFEROXAMINE; GELATINASE A; MATRIX METALLOPROTEINASE INHIBITOR; SYNAPTOPHYSIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AVERSIVE BEHAVIOR; BRAIN DYSFUNCTION; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; ENCEPHALITIS; HIPPOCAMPUS; INFLAMMATION; MALE; MEMORY; NONHUMAN; OXIDATIVE STRESS; PREFRONTAL CORTEX; RAT; REVIEW; SEPSIS; SURVIVOR; TRAINING; WESTERN BLOTTING;

ACUTE DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL MARKERS; COGNITION DISORDERS; ENCEPHALITIS; MALE; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; RATS; RATS, WISTAR; SEPSIS; SURVIVORS; SYNAPTOPHYSIN; TIME FACTORS;

EID: 84894313474     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8526-3     Document Type: Review

References (34)

1. Iacobone E, Bailly-Salin J, Polito A, Friedman D, Stevens RD, Sharshar T (2009) Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 37:S331-S336
2. Semmler A, Widmann CN, Okulla T, Urbach H, Kaiser M, Widman G, Mormann F, Weide J, Floessbach K, Hoeft A, Jessen F, Putensen C, Heneka MT (2013) Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatry 84:62-69
3. Bozza F, D'Avila JC, Ritter C, Sonneville R, Sharshar T, Dal-Pizzol F (2013) Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy. Shock 39:10-16
4. Barichello T, Martins MR, Reinke A, Feier G, Ritter C, Quevedo J, Dal-Pizzol F (2005) Long-term cognitive impairment in sepsis survivors. Crit Care Med 33:1671
5. Barichello T, Machado RA, Constantino L, Valvassori SS, Reus GZ, Martins MR, Petronilho F, Ritter C, Quevedo J, Dal-Pizzol F (2007) Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med 35:2186-2190
6. Dal-Pizzol F, Rojas HA, dos Santos EM, Vuolo F, Constantino L, Feier G, Pasquali M, Comim CM, Petronilho F, Gelain DP, Quevedo J, Moreira JC, Ritter C (2013) Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis. Mol Neurobiol 48:62-70
7. van Gool WA, van de Beek D, Eikelenboom P (2010) Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 375:773-775
8. Buckingham SD, Jones AK, Brown LA, Sattelle DB (2009) Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 61:39-61
9. Semmler A, Frisch C, Debeir T, Ramanathan M, Okulla T, Klockgether T, Heneka MT (2007) Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol 204:733-740
10. Comim CM, Pereira JG, Steckert A, Petronilho F, Barichello T, Quevedo J, Dal-Pizzol F (2009) Rivastigmine reverses habituation memory impairment observed in sepsis survivor rats. Shock 32:270-271
11. Tillement JP, Lecanu L, Papadopoulos V (2010) Amyloidosis and neurodegenerative diseases: current treatments and new pharmacological options. Pharmacology 85:1-17
12. Haapasalo A, Viswanathan J, Bertram L, Soininen H, Tanzi RE, Hiltunen M (2010) Emerging role of Alzheimer's disease-associated ubiquilin-1 in protein aggregation. Biochem Soc Trans 38:150-155
13. Tan JM, Wong ES, Lim KL (2009) Protein misfolding and aggregation in Parkinson's disease. Antioxid Redox Signal 11:2119-2134
14. Dal-Pizzol F, Pasquali M, Quevedo J, Gelain DP, Moreira JC (2012) Is there a role for high mobility group box 1 and the receptor for advanced glycation end products in the genesis of long-term cognitive impairment in sepsis survivors? Mol Med 18:1357-1358
15. Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 29:189-201
16. Ritter C, Andrades M, Frota Júnior ML, Bonatto F, Pinho RA, Polydoro M, Klamt F, Pinheiro CT, Menna-Barreto SS, Moreira JC, Dal-Pizzol F (2003) Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med 29:1782-1789
17. Quevedo J, Vianna MR, Roesler R, Izquierdo I (1999) Two time windows of anisomycin-induced amnesia for inhibitory avoidance training in rats: protection from amnesia by pretraining but not pre-exposure to the task apparatus. Learn Mem 6:600-607
18. Ernst A, Morgenthaler NG, Buerger K, Dodel R, Noelker C, Sommer N, Schwarz M, Koehrle J, Bergmann A, Hampel H (2007) Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation. J Neuroimmunol 189:169-174
19. Weberpals M, Hermes M, Hermann S, Kummer MP, Terwel D, Semmler A, Berger M, Schafers M, Heneka MT (2009) NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J Neurosci 29:14177-14184
20. Barichello T, Fortunato JJ, Vitali AM, Feier G, Reinke A, Moreira JC, Quevedo J, Dal-Pizzol F (2006) Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Crit Care Med 34:886-889
21. Jeremias IC, Scaini G, Constantino L, Vuolo F, Ferreira AK, Scherer EB, Kolling J, da Silva DA, de Souza Wyse AT, Bogo MR, Dal-Pizzol F, Streck EL (2012) The decrease on Na(+), K(+)-ATPase activity in the cortex, but not in hippocampus, is reverted by antioxidants in an animal model of sepsis. Mol Neurobiol 46:467-474
22. Comim CM, Barichello T, Grandgirard D, Dal-Pizzol F, Quevedo J, Leib SL (2013) Caspase-3 mediates in part hippocampal apoptosis in sepsis. Mol Neurobiol 47:394-398
23. Tweedie D, Ferguson RA, Fishman K, Frankola KA, Van Praag H, Holloway HW, Luo W, Li Y, Caracciolo L, Russo I, Barlati S, Ray B, Lahiri DK, Bosetti F, Greig NH, Rosi S (2012) Tumor necrosis factor-alpha synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease. J Neuroinflammation 9:106
24. Biff D, Petronilho F, Constantino L, Vuolo F, Zamora-Berridi GJ, Dall'Igna DM, Comim CM, Quevedo J, Kapczinski F, Dal-Pizzol F (2013) Correlation of acute phase inflammatory and oxidative markers with long-term cognitive impairment in sepsis survivors rats. Shock 40:45-48
25. Cras P, Kawai M, Siedlak S, Mulvihill P, Gambetti P, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1990) Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol 137:241-246
26. Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 149:21-28
27. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421
28. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23:2375-2378
29. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759-767
30. Baruch-Suchodolsky R, Fischer B (2009) Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems. Biochemistry 48:4354-4370
31. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5:e9505
32. Rao JS, Kellom M, Kim HW, Rapoport SI, Reese EA (2012) Neuroinflammation and synaptic loss. Neurochem Res 37:903-910
33. Garrido P, De Blas M, Giné E, Santos Á, Mora F (2012) Aging impairs the control of prefrontal cortex on the release of corticosterone in response to stress and on memory consolidation. Neurobiol Aging 33:827.e1-827.9
34. Cassol-Jr OJ, Comim CM, Petronilho F, Constantino LS, Streck EL, Quevedo J, Dal-Pizzol F (2010) Low dose dexamethasone reverses depressive-like parameters and memory impairment in rats submitted to sepsis. Neurosci Lett 473:126-130